Direct inhibitory effects of Ganciclovir on ICAM-1 expression and proliferation in human coronary vascular cells (SI/MPL-ratio: >1).
Pulsed perfusion in a venous human organ culture model with a Windkessel function (pulsed perfusion venous HOC-model).
Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
Low-dose irradiation stimulates TNF-alpha-induced ICAM-1 mRNA expression in human coronary vascular cells.
A perfused renal human organ culture model: impact of monocyte attack.
HCMV-infection in a human arterial organ culture model: effects on cell proliferation and neointimal hyperplasia.
Sirolimus inhibits key events of restenosis in vitro/ex vivo: evaluation of the clinical relevance of the data by SI/MPL- and SI/DES-ratios.
Chlamydia pneumoniae in an ex vivo human artery culture model.
Edge restenosis: impact of low dose irradiation on cell proliferation and ICAM-1 expression.
Antiproliferative profile of sirolimus and mycophenolate mofetil: impact of the SI/MPL ratio.
Triple-coated stents (Hirudin/Iloprost/Paclitaxel): an in vitro approach for characterizing the antiproliferative potential of each individual compound.
Rapamycin attenuates vascular wall inflammation and progenitor cell promoters after angioplasty.
Effects of mycophenolate mofetil on key pattern of coronary restenosis: a cascade of in vitro and ex vivo models.
Human cytomegalovirus infection in human renal arteries in vitro.
Simultaneous intra/extravascular administration of antiproliferative agents as a new strategy to inhibit restenosis: the peak of reactive cell proliferation as a hallmark for the duration of the treatment.
Leukocyte attack in a 3D human coronary in-vitro model.
Aspirin (5 mmol/L) inhibits leukocyte attack and triggered reactive cell proliferation in a 3D human coronary in vitro model.
Different effects of antisense RelA p65 and NF-kappaB1 p50 oligonucleotides on the nuclear factor-kappaB mediated expression of ICAM-1 in human coronary endothelial and smooth muscle cells.
Different radiosensitivity of smooth muscle cells and endothelial cells in vitro as demonstrated by irradiation from a Re-188 filled balloon catheter.
Intracoronary beta-irradiation with a liquid (188)re-filled balloon: six-month results from a clinical safety and feasibility study.
A human arterial organ culture model of postangioplasty restenosis: results up to 56 days after ballooning.
Altered expression of extracellular matrix in human-cytomegalovirus-infected cells and a human artery organ culture model to study its biological relevance.
Modulation of Ca2+-activated K+ channels in human vascular cells by insulin and basic fibroblast growth factor.
Effect of diltiazem and verapamil on endothelin release by cultured human coronary smooth-muscle cells and endothelial cells.
Effect of the antioxidant Nicanartine on the proliferative and inflammatory response after experimental balloon angioplasty.
Expression of intercellular adhesion molecule-1 in human coronary endothelial and smooth muscle cells after stimulation with tumor necrosis factor-alpha.
Ca(2+)-activated K+ channels in human smooth muscle cells of coronary atherosclerotic plaques and coronary media segments.
Estradiol concentrations in premenopausal women with coronary heart disease.
High-dose diltiazem prevents migration and proliferation of vascular smooth muscle cells in various in-vitro models of human coronary restenosis.
Increased endothelin release by cultured human smooth muscle cells from atherosclerotic coronary arteries.
A coronary porcine organ culture system for studies of postangioplasty cell proliferation.
A prescreening system for potential antiproliferative agents: implications for local treatment strategies of postangioplasty restenosis.
[Recurrent stenosis following coronary angioplasty. Clinical, cell biological and molecular aspects].
Cyclosporine A stimulates endothelin release.
Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro.
The in-vitro effect of antineoplastic agents on proliferative activity and cytoskeletal components of plaque-derived smooth-muscle cells from human coronary arteries.
[Hormone therapy as a therapeutic option in prevention of restenosis after angioplasty? Analysis of estrogen and progesterone receptors in human coronary plaque cells in vitro].
[Search for new strategies for prevention of restenosis after angioplasty: the effect of cytostatic drugs on cell migration of re-stenosing human plaque cells in vitro]
[The effect of propranolol, lisinopril, prednisolone, colchicine, etoposide and vincristine on proliferation of re-stenosing human plaque cells in vitro: cell culture as a prescreening system for prevention of restenosis]
[Cell culture as a prescreening system for drug prevention of restenosis?]
[In vitro balloon treatment of coronary plaque material of the human: effect of dilation time on proliferation of smooth muscle cells].
[Proliferation and migration behavior of coronary primary stenosis cells in the transfilter culture system]
Growth characteristics and cytoskeletal organization of cultured smooth muscle cells from human primary stenosing and restenosing lesions.
In vitro growth characteristics of human atherosclerotic plaque cells: comparison of cells from primary stenosing and restenosing lesions of peripheral and coronary arteries.
[The effect of diltiazem on plaque cells of primary and restenosed lesions]
Selective percutaneous "biopsy" of atheromatous plaque tissue for cell culture.
[Selective biopsy of plaque material for cell cultivation]